As liver fibrosis advances, the mRNA level of FGF21 gradually increases, and Interleukin (IL)-1β, through the NF-κB and JNK pathways, gradually enhances the expression of FGF21, thereby inhibiting liver fibrosis (Lee et al., 2018). Here, IL1B is linked to Hepatic fibrosis.